The Role of Blood Purification by Hemoadsorption as Adjunctive Treatment in Children With Septic Shock

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Septic ShockMulti Organ Failure
Interventions
DEVICE

HA330 hemoadsorption technique

Hemoadsorption (HA) treatment An HA330 disposable hemoperfusion cartridge (HA330; Jafron, Zhuhai City, China) was used with a continuous renal replacement therapy (CRRT) machine (Aquarius® or Primaflex®) in the intervention group. We will select a blood circuit for each machine according to the patient's body weight. Vascular access will be established with ultrasound-guided insertion of a double-lumen venous catheter into the right internal jugular or femoral vein. HA will be performed for a maximum of 4 hours, and the second session will be started approximately 24 hours after the end of the first session. The blood flow rate will be started low and be gradually increased while monitoring real-time blood pressure and vital signs with an arterial-line monitor. After the end of the HA session, CRRT will be continued if required.

Trial Locations (1)

10330

Faculty of Medicine, Chulalongkorn University, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER